Skip to content
Home/Companies/Healthcare/BigHat Biosciences
BigHat Biosciences

BigHat Biosciences

Healthcare·US·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns BigHat Biosciences?

BigHat Biosciences is currently owned by Quadrille Capital through Quadrille Technologies IV (2021 vintage), since 2022.

Hand-verified · updated 2026-04-21

Quadrille Capital
Investor
Quadrille Capital
Quadrille Technologies IV · 2021 · VC

Key facts

HQFrance
SectorHealthcare
Websitewww.bighatbio.com

More from Quadrille Technologies IV

Other portfolio companies in the same fund.

Amboss
Active
HealthTechGermany· 2025
Sanas
Active
SoftwareUS· 2025
Exoticca
Exoticca
Active
ConsumerSpain· 2024
Wisetack
Active
FinancialsUS· 2024
Hivebrite
Hivebrite
Active
SaaSFrance· 2023
Medwing
Medwing
Active
HealthcareGermany· 2023

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Track BigHat Biosciences

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy BigHat Biosciences?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on BigHat Biosciences.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue